<DOC>
	<DOCNO>NCT00882024</DOCNO>
	<brief_summary>The purpose study evaluate whether tranilast two different dosage compare placebo effective patient active RA add continue methotrexate ( MTX ) therapy .</brief_summary>
	<brief_title>Safety Efficacy Study Tranilast Patients With Active Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description>The primary objective study assess efficacy safety two different dos tranilast determined ACR20 response 12 week .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tranilast</mesh_term>
	<criteria>Receiving methotrexate Have least 8 painful/tender 6 swollen joint May receive oral steroid , chronic NSAIDs and/or hydroxychloroquine . Use antiarthritic treatment except allow inclusion criterion Pregnant nursing female Abnormal laboratory value History clinically significant renal , hepatic dysfunction , psychiatric disorder , alcohol/drug dependence Clinically significant systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>